Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950170-24-009495)

Filing Details

Accession Number:: 0000950170-24-009495
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-01-31 17:30:13
Reporting Period:: 2024-01-29

Accepted Time:: 2024-01-31 17:30:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1422143	Kura Oncology Inc.	KURA	Pharmaceutical Preparations (2834)	611547851

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1813058	Brophy Teresa Bair	C/O Kura Oncology, Inc. 12730 High Bluff Drive, Suite 400 San Diego CA 92130	Chief Legal Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-01-29	2,053	$17.80	68,979	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/23.